SBIR/STTR Research Award
A MULTIFUNCTIONAL POINT-OF-CARE PLATFORM TO DIFFERENTIATE HIV INFECTION FROM VACCINE INDUCED SEROPOSITIVITY
Award amount
$1,999,995Program and phase
SBIR · Phase IIAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BAEBIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NZSZBQ9B84T1
- Solicitation number
- PHS 2023-1
- Topic code
- 115
Research abstract
Development of Diagnostics to Differentiate HIV Infection from Vaccine-Induced Seropositivity: The overarching goal of this program is to support the development of new serological and nucleic acid assays that can identify HIV infection while avoiding false-positive results due to vaccine-induced seropositivity (VISP), with high sensitivity and specificity. These next generation assays should be developed to address one or all applications/indications of HIV tests, namely: (1) laboratory based tests; ((2) point-of-care and clinical practices; and (3) self-testing. This contract aims to develop a novel diagnostic platform that automates a HIV-1 qualitative reverse transcription PCR (RT-PCR) test together with two direct antibody binding assays to differentiate HIV-1 infection from VISP.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Development of a Wide Multiplexing, Multifunctional Platform for Flexible Diagnostics
- DEVELOPMENT OF A RAPID, QUANTITATIVE HIV-1 ASSAY FOR VIRAL LOAD SELF-MONITORING
- Sample-to-Answer Detection of Hepatitis C Virus from Fingerstick Whole Blood via a Robust, Accessible Digital Microfluidic Device
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- ""A MULTIFUNCTIONAL POINT-OF-CARE PLATFORM TO DIFFERENTIATE HIV INFECTION FROM VACCINE INDUCED SEROPOSITIVITY""
- ""THE EV-HIV ASSAY, A POINT-OF-CARE LATERAL FLOW IMMUNOASSAY TO ACCURATELY IDENTIFY HIV INFECTION FROM BLOOD-BASED EXTRACELLULAR VESICLES""
- ""MULTIPLEXED DROPLET DIGITAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES FOR HIV DIAGNOSIS""
Research funding history
45 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $42,450,057. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense